Navigation Links
Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets
Date:6/20/2013

SYDNEY and WESTMINSTER, Colo., June 20, 2013 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and US-based Surefire Medical today announced a sales and marketing partnership to distribute Surefire's range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.

The agreement will see Sirtex exclusively distribute the Surefire Medical range of products in the company's rapidly growing Asia Pacific markets including Australia.

Sirtex reported a 30 per cent growth in dose sales of its targeted radiation treatment for liver cancer in the Asia Pacific region at the end of the third quarter ended 31 March 2013.

Rapidly growing Surefire Medical has received regulatory approval in the U.S., Europe, Canada and New Zealand.  Its first-in-class infusion systems are used by numerous top-ranked cancer centers and hospitals in these markets.

The Surefire Infusion System has been designed to enhance the accuracy and delivery of drugs directly to tumors.  Surefire products use a patented microcatheter with an expandable tip. When deployed, the tip dynamically responds to flow conditions to enable more of the embolic agent to reach the intended destination while reducing non-target delivery compared to traditional infusion systems.

The ability to more safely and efficiently deliver embolic agents directly to target tumors marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.

Sirtex Medical Asia Pacific Chief Executive Officer Dr. Burwood Chew said, "Sirtex is constantly looking for new ways to help our customers improve the outcomes of their patients with liver cancer.  We believe this distribution partnership will allow us to provide interventional radiologists and oncologists with a wider range of options that may potentially lead to improved patient outcomes, which is our shared goal."

Surefire Medical CEO Jim Chomas said, "A growing body of positive clinical evidence and the enthusiasm of our increasing user base at hospitals worldwide continue to prove the efficacy of the Surefire line of infusion systems.  The agreement with Sirtex enables our companies to jointly pursue more effective treatment for the rising worldwide incidence of liver cancer."

For further information please refer to www.surefiremedical.com and sirtex.com  

SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
2. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
3. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
4. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
5. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Cad Software
6. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Volpara Breast Density Software
7. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
8. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
9. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
10. Christopher Mennone Joins Surefire Medical Team As International Business Director
11. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology:
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... ... in the Orthodontics and Clear Aligner clinical and commercial support services market) has ... of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... In just ... Brain Booster has already been receiving positive feedback from customers trying the product for ... , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
Breaking Medicine News(10 mins):